ZEPP
Zepp Health Corporation
3.70$
-3.1%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 51.8% | 49.8% | 47.0% | 46.7% | 46.4% | 47.6% | 46.7% | 49.6% | 53.2% | 52.0% | 48.7% | 50.5% | |
| 20.3% | 22.1% | 22.7% | 20.5% | 21.7% | 20.9% | 20.0% | 17.4% | 10.5% | 20.0% | 19.4% | 19.0% | |
| 20.9% | 22.9% | 23.7% | 155.3% | 22.5% | 21.1% | 20.2% | 17.5% | 10.7% | 20.0% | 19.4% | 19.0% | |
| 12.0% | 12.9% | 7.7% | 7.3% | 7.7% | 15.0% | 10.7% | 13.6% | 14.9% | 13.0% | 11.7% | 14.8% | |
| 16.3% | 13.4% | 12.5% | 12.5% | 13.0% | 10.7% | 12.4% | 14.6% | 15.0% | 12.9% | 11.8% | 11.2% | |
| 16.9% | – | – | – | – | – | – | – | – | – | – | – | |
| 1.4% | 1.5% | 1.6% | 1.7% | 1.6% | 1.8% | 1.8% | 1.7% | 1.6% | 1.7% | 1.8% | 1.7% | |
| 2.2% | 1.6% | 1.6% | 1.5% | 1.4% | 1.3% | 2.9% | 2.6% | 2.3% | 2.4% | 2.5% | 2.3% | |
| 47.5% | 44.5% | 42.6% | 44.1% | 46.4% | 52.2% | 55.3% | 58.9% | 61.4% | 62.0% | 63.5% | 67.0% | |
| 25.3% | 24.4% | 27.4% | 33.7% | 38.3% | 37.0% | 40.9% | 45.2% | 48.8% | 50.8% | 55.3% | 56.2% | |
| 11.7% | 11.4% | 16.8% | 163.0% | 26.2% | 19.8% | 22.1% | 22.2% | 23.8% | 29.6% | 37.2% | 33.7% | |
| 9.1% | 5.9% | 3.6% | 4.6% | 5.5% | 9.7% | 11.7% | 15.8% | 17.9% | 14.3% | 11.1% | 15.7% | |
| 130.2% | 134.1% | 13.9% | 9.2% | 1.0% | 2.0% | 1.8% | 1.8% | 11.9% | 1.5% | 1.1% | 1.5% | |
| 52.2% | 55.2% | 57.2% | 55.7% | 53.4% | 47.6% | 44.7% | 41.1% | 38.6% | 38.0% | 36.5% | 33.0% | |
| 15.3% | 16.4% | 14.8% | 13.6% | 11.1% | 5.4% | 1.7% | 0.2% | -0.1% | -2.0% | -5.8% | -7.6% | |
| 2.4% | 2.4% | 0.4% | 10.2% | 0.4% | 0.4% | 0.4% | 0.4% | 2.7% | 0.0% | 0.0% | 0.0% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.